Results 71 to 80 of about 2,118 (153)

"Selective" serotonin 5-HT_2A receptor antagonists. [PDF]

Biochem Pharmacol, 2022
Casey AB, Cui M, Booth RG, Canal CE.
europepmc   +1 more source

Pathway-specific regulation of the paraventricular thalamic nucleus in depressive-like behavior. [PDF]

Sci Rep
Kassai M, Tachibana D, Sato F, Miyanishi H, Yoshida H, Kato T, Sakashita-Kubota M, Kato T, Shima Y.   +8 more
europepmc   +1 more source

Endoplasmic reticulum secretory pathway: Potential target against SARS-CoV-2. [PDF]

Virus Res, 2022
Upadhyay M, Gupta S.
europepmc   +1 more source

Repurposing Caffeine, Metformin, and Furosemide to Target Schizophrenia-Related Impairments in a Triple-Hit Rat Model. [PDF]

Int J Mol Sci
Horvath G, Plesz SB, Ducza E, Varga D, Szucs E, Benyhe S, Adlan LG, Braunitzer G, Kekesi G.   +8 more
europepmc   +1 more source

Dopamine receptors and organ fibrosis. [PDF]

Biochem Biophys Rep
Liao Z, Tang X, Yang B, Yang J.
europepmc   +1 more source

Bioisosteric Replacement of Amides with 1,2,3-Triazoles Improves Dopamine D4 Receptor Ligand Pharmacokinetics. [PDF]

ACS Pharmacol Transl Sci
Alkhatib M, Jakobs FM, Hanson JN, Nilson AN, Moritz AE, Li T, Faibille AB, Bourn LA, Ramdhan PA, Ricchezza J, Jordan S, Panasis D, Nguyen N, Kasarla N, Wang B, Garcia SS, Saez J, Paule J, Lee CB, Rais R, Slusher BS, Sibley DR, Li C, Keck TM, Boateng CA.   +24 more
europepmc   +1 more source

Virtual Screening Approaches to Identify Promising Multitarget-Directed Ligands for the Treatment of Autism Spectrum Disorder. [PDF]

Molecules
Jończyk J, Przybylska K, Staszewski M, Godyń J, Werner T, Stefaniak-Napieralska M, Stark H, Walczyński K, Bajda M.   +8 more
europepmc   +1 more source

Envisioning Cannabinoid CB1 Receptor Biased Signaling as a Therapeutic Target for Schizophrenia. [PDF]

Am J Psychiatry
Ku SH, Stringfield SJ, Torregrossa MM, Sweet RA, Chou S.   +4 more
europepmc   +1 more source

Orexins, Psychosis, and Antipsychotics: A Systematic Review of Studies of Orexin Levels and the Effects of Dual Orexin Receptor Antagonists (DORAs). [PDF]

Brain Sci
Margoni S, Hasaj S, Donofrio G, Kotzalidis GD, Callovini T, Pinto M, Scialpi C, Bucci M, Anesini MB, Sani G, Moccia L, Janiri D.   +11 more
europepmc   +1 more source

Receptor interaction profiles of 4-alkoxy-2,6-dimethoxyphenethylamines (Ψ derivatives) and related amphetamines. [PDF]

Front Pharmacol
Kolaczynska KE, Trachsel D, Hoener MC, Liechti ME, Luethi D.   +4 more
europepmc   +1 more source